Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2022-07-18 00:00:00 ET · period of report 2022-07-15 · accession 0001567619-22-014114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-18 | 2022-07-15 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $21.32 | -12.4K | 80.5K | -13% | -$264.3K |
| D | 2022-07-18 | 2022-07-15 | ANGO | Trowbridge Stephen A | EVP, CFO | M - OptEx | $15.95 | +14.8K | 92.9K | +19% | +$235.4K |
| D | 2022-07-18 | 2022-07-15 | ANGO | Trowbridge Stephen A | EVP, CFO | M - OptEx | $0.00 | -14.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-15 | F | D | 12,398 | $21.32 | 80,537 | D | — | — | (F1) The exempt disposition of 12,398 shares of common stock of AngioDynamics, Inc. (the "Company") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022. |
| 2 | Common | Common Stock | 2022-07-15 | M | A | 14,758 | $15.95 | 92,935 | D | — | — | |
| 3 | Derivative | Non- Qualified Stock Option (right to buy) | 2022-07-15 | M | D | 14,758 | $0.00 | 0 | D | $15.95 · 2016-07-22 to 2022-07-22 | 14,758 Common Stock | (F2) Options for one-fourth of the shares were each exercisable beginning 7/22/2016, 7/22/2017, 7/22/2018 and 7/22/2019, respectively. |